INDUCTION OF TISSUE FACTOR-LIKE ACTIVITY IN MONOCYTES BY ANTICARDIOLIPIN ANTIBODIES

被引:0
作者
KORNBERG, A
BLANK, M
KAUFMAN, S
SHOENFELD, Y
机构
[1] TEL AVIV UNIV, SACKLER FAC MED, IL-69978 TEL AVIV, ISRAEL
[2] CHAIM SHEBA MED CTR, STEINMETZ RES UNIT AUTOIMMUNE DIS, TEL HASHOMER, ISRAEL
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Anti-cardiolipin Abs (ACLA) are present in the sera of patients with antiphospholipid syndrome (APLS) and are associated with high incidence of thromboembolic phenomena, fetal loss, thrombocytopenia, and prolongation of the phospholipid-dependent coagulation assays (lupus anticoagulant). Recently, it has been shown that APLS can be induced experimently by using ACLA. However, the pathophysiology of thrombus formation in this syndrome is unknown. Monocytes generate a potent procoagulant activity (PCA) after stimulation with various substances. Increased PCA has been found in monocytes from patients with diseases that are associated with high incidence of thromboembolic phenomena. In the present study, we report that the monoclonal ACLA that were shown previously by us to induce APLS stimulate mononuclear cells to generate a potent PCA. The PCA resembled tissue factor (TF) in that it accelerated clotting through the extrinsic coagulation pathway, was abolished by phospholipase C, and was inhibited by anti-TF mAbs. The induction of TF-like activity by ACLA in monocytes was dose- and time-dependent. It was induced in monocytes and monocytic cell lines, but not in lymphoid or myeloid cells, and did not require T lymphocytes for expression. The generation of PCA was dependent on protein synthesis inasmuch as it was prevented by adding puromycin to the system and was not affected by cytarabine. The TF-like activity that is induced by ACLA in monocytes may activate coagulation and thereby play a major role in the pathogenesis of thrombus formation in APLS.
引用
收藏
页码:1328 / 1332
页数:5
相关论文
共 33 条
[1]  
ANGLESCANO E, 1979, J LAB CLIN MED, V94, P312
[2]   INDUCTION OF PRIMARY ANTIPHOSPHOLIPID SYNDROME IN MICE BY IMMUNIZATION WITH A HUMAN MONOCLONAL ANTICARDIOLIPIN ANTIBODY (H-3) [J].
BAKIMER, R ;
FISHMAN, P ;
BLANK, M ;
SREDNI, B ;
DJALDETTI, M ;
SHOENFELD, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (05) :1558-1563
[3]   ANTICARDIOLIPIN ANTIBODIES AND THROMBOSIS [J].
BICK, RL ;
BAKER, WF .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (06) :1287-1299
[4]   THE ANTIPHOSPHOLIPID-THROMBOSIS SYNDROMES - FACT, FICTION, CONFUSION, AND CONTROVERSY [J].
BICK, RL .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 100 (05) :477-480
[5]   THE DEVELOPMENT OF MONOSPECIFIC ANTIBODIES AGAINST HUMAN THROMBOPLASTIN APOPROTEIN (APOPROTEIN-III) AND THEIR APPLICATION IN THE IMMUNOCYTOCHEMICAL DETECTION OF THE ANTIGEN IN BLOOD-CELLS [J].
BJORKLID, E ;
HOLM, T ;
OSTERUD, B .
THROMBOSIS RESEARCH, 1987, 45 (05) :609-624
[6]   INDUCTION OF ANTIPHOSPHOLIPID SYNDROME IN NAIVE MICE WITH MOUSE LUPUS MONOCLONAL AND HUMAN POLYCLONAL ANTICARDIOLIPIN ANTIBODIES [J].
BLANK, M ;
COHEN, J ;
TODER, V ;
SHOENFELD, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (08) :3069-3073
[7]   INDUCTION OF EXPERIMENTAL ANTIPHOSPHOLIPID SYNDROME ASSOCIATED WITH SLE FOLLOWING IMMUNIZATION WITH HUMAN MONOCLONAL PATHOGENIC ANTI-DNA IDIOTYPE [J].
BLANK, M ;
KRAUSE, I ;
BENBASSAT, M ;
SHOENFELD, Y .
JOURNAL OF AUTOIMMUNITY, 1992, 5 (04) :495-509
[8]   THE PRODUCTION OF HUMAN MONOCLONAL ANTI-MMTV ANTIBODIES BY INVITRO IMMUNIZATION WITH ANTIIDIOTYPIC ANTIBODIES [J].
BLANK, M ;
SMORODINSKY, IN ;
KEYDAR, I ;
CHAITCHIK, S ;
SHOENFELD, Y .
IMMUNOLOGY LETTERS, 1991, 28 (01) :65-72
[9]  
CARIOU R, 1986, NEW ENGL J MED, V314, P1193
[10]  
CARRERAS LO, 1981, LANCET, V1, P244